Belvedere Trading
DCPH

Belvedere Trading’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Belvedere Trading’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-14,463
Closed -$204K – 1045
2023
Q2 		$204K Buy
14,463
+597
+4% +$8.54K ﹤0.01% 308
2023
Q1 		$214K Buy
+13,866
New +$232K ﹤0.01% 312

Other funds holding DCPH

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Belvedere Trading's DCPH Position: Q3 2023 in Review

Belvedere Trading sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q3 2023, closing a stake of 14,463 shares — an estimated $204K sold.

Belvedere Trading first reported a position in DCPH in Q1 2023 and held it in 2 quarters. The position peaked at $214K in Q1 2023. 157 funds tracked by Wall St. Rank hold DCPH as of Q3 2023.

  • Belvedere Trading reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Belvedere Trading sold 14,463 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q3 2023, an estimated $204K.
  • Belvedere Trading first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2023 and held it in 2 quarters.
  • Belvedere Trading's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $214K in Q1 2023.
  • 157 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q3 2023.

Based on Belvedere Trading's 13F filing for Q3 2023, filed 27 Oct 2023.